首页 > 最新文献

CVIR Endovascular最新文献

英文 中文
Stent-graft implantation for hepatic arterial bleeding: a systematic review and meta-analysis. 支架植入术治疗肝动脉出血:系统回顾和荟萃分析。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-13 DOI: 10.1186/s42155-025-00608-0
Sinan Deniz, Elif Öcal, Muzaffer Reha Ümütlü, Moritz Wildgruber, Jens Ricke, Max Seidensticker, Osman Öcal

Purpose: The aim of this systematic review and meta-analysis was to identify the technical and clinical outcomes of stent-graft implantation in patients with hepatic artery bleeding.

Materials and methods: The PubMed database was searched for publications between 2000 and March 2025 evaluating patients treated with stent-graft implantation for hepatic arterial hemorrhage. The outcome measurements were technical (successful hemostasis with stent-grafts) and clinical success (no rebleeding from hepatic arteries), early mortality, and stent-graft patency during follow-up. A modified Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included publications. An individual patient data meta-analysis was performed using the chi-square test or Fischer exact test to identify predictors of stent-graft patency.

Results: In total, 351 patients from 22 studies were included. The mean NOS score was 5.4 ± 0.95. Most patients (n = 323) had bleeding after surgery. The technical success rate of stent-graft placement was 94.3%. Patients with technical failure were managed either by surgery (n = 10) or coil embolization of the hepatic artery (n = 10). Rebleeding from hepatic arteries was seen in 24 patients with a clinical success rate of 92.7%. The early mortality rate was 15.6%. Follow-up showed stent-graft patency in 76.5% (202 of 264) of the cases. Most of the stent-graft occlusions (51/62, 82.2%) were asymptomatic. No significant difference was seen in the rate of stent-graft patency between patients receiving acetylsalicylic acid or not, or dual antiplatelet treatment or not. Overlapping stent-grafts (p = 0.009) were significant risk factors for stent-graft occlusion.

Conclusion: Stent-graft implantation in hepatic arterial bleeding is associated with high technical and clinical success rates. Despite the considerable rate of stent-graft occlusion during follow-up, occlusion is mostly asymptomatic, probably due to collateral development.

目的:本系统综述和荟萃分析的目的是确定肝动脉出血患者支架植入术的技术和临床结果。材料和方法:检索PubMed数据库,检索2000年至2025年3月期间评估接受支架植入治疗肝动脉出血患者的出版物。结果测量是技术(支架移植成功止血)和临床成功(无肝动脉再出血),早期死亡率和随访期间支架移植通畅。采用改良的纽卡斯尔-渥太华量表(NOS)评估纳入出版物的质量。使用卡方检验或Fischer精确检验对个体患者数据进行meta分析,以确定支架通畅的预测因素。结果:共纳入22项研究的351例患者。NOS平均评分为5.4±0.95。大多数患者(n = 323)术后出血。支架置入术成功率为94.3%。技术失败的患者通过手术(n = 10)或肝动脉线圈栓塞(n = 10)进行治疗。肝动脉再出血24例,临床成功率92.7%。早期死亡率为15.6%。随访显示76.5%(264例中202例)的患者支架通畅。大多数支架闭塞无症状(51/62,82.2%)。接受与不接受乙酰水杨酸或双重抗血小板治疗的患者的支架通畅率无显著差异。重叠支架(p = 0.009)是支架闭塞的重要危险因素。结论:肝动脉出血支架植入术具有较高的技术和临床成功率。尽管在随访期间有相当比例的支架-移植物闭塞,闭塞大多是无症状的,可能是由于侧枝发育。
{"title":"Stent-graft implantation for hepatic arterial bleeding: a systematic review and meta-analysis.","authors":"Sinan Deniz, Elif Öcal, Muzaffer Reha Ümütlü, Moritz Wildgruber, Jens Ricke, Max Seidensticker, Osman Öcal","doi":"10.1186/s42155-025-00608-0","DOIUrl":"10.1186/s42155-025-00608-0","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this systematic review and meta-analysis was to identify the technical and clinical outcomes of stent-graft implantation in patients with hepatic artery bleeding.</p><p><strong>Materials and methods: </strong>The PubMed database was searched for publications between 2000 and March 2025 evaluating patients treated with stent-graft implantation for hepatic arterial hemorrhage. The outcome measurements were technical (successful hemostasis with stent-grafts) and clinical success (no rebleeding from hepatic arteries), early mortality, and stent-graft patency during follow-up. A modified Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included publications. An individual patient data meta-analysis was performed using the chi-square test or Fischer exact test to identify predictors of stent-graft patency.</p><p><strong>Results: </strong>In total, 351 patients from 22 studies were included. The mean NOS score was 5.4 ± 0.95. Most patients (n = 323) had bleeding after surgery. The technical success rate of stent-graft placement was 94.3%. Patients with technical failure were managed either by surgery (n = 10) or coil embolization of the hepatic artery (n = 10). Rebleeding from hepatic arteries was seen in 24 patients with a clinical success rate of 92.7%. The early mortality rate was 15.6%. Follow-up showed stent-graft patency in 76.5% (202 of 264) of the cases. Most of the stent-graft occlusions (51/62, 82.2%) were asymptomatic. No significant difference was seen in the rate of stent-graft patency between patients receiving acetylsalicylic acid or not, or dual antiplatelet treatment or not. Overlapping stent-grafts (p = 0.009) were significant risk factors for stent-graft occlusion.</p><p><strong>Conclusion: </strong>Stent-graft implantation in hepatic arterial bleeding is associated with high technical and clinical success rates. Despite the considerable rate of stent-graft occlusion during follow-up, occlusion is mostly asymptomatic, probably due to collateral development.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"80"},"PeriodicalIF":1.5,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12518196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostatic artery from an extrapelvic obturator artery: a rare common femoral artery variant with clinical implications. 前列腺动脉源自骨盆外闭孔动脉:一种罕见的常见股动脉变异,具有临床意义。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-11 DOI: 10.1186/s42155-025-00594-3
Omar Ayman, Paul Bennett Lewis

Background: Prostate artery embolization (PAE) is an established treatment option for benign prostatic hyperplasia (BPH). Variations in prostatic artery (PA) origins can present significant technical challenges.

Case presentation: An 86-year-old male with recurrent bladder cancer and persistent gross hematuria post-TURBT presented for PAE. Intra-procedural angiography revealed a prostatic artery branching from an aberrant obturator artery that originated from a trifurcation of the common femoral artery. PAE was successfully performed with contralateral access and particle embolization. The patient's hematuria resolved within 3 days, and his IPSS decreased by 10 points at follow-up.

Conclusion: This case highlights a markedly rare variant of the prostatic artery arising from the common femoral artery, emphasizing the need for careful pre-procedural planning and vigilance during PAE to avoid complications.

背景:前列腺动脉栓塞(PAE)是治疗良性前列腺增生(BPH)的常用方法。前列腺动脉(PA)起源的变化可能带来重大的技术挑战。病例介绍:86岁男性膀胱癌复发和持续肉眼血尿后turt提出PAE。术中血管造影显示前列腺动脉起源于股总动脉三岔的异常闭孔动脉分支。通过对侧通路和颗粒栓塞成功进行了PAE。患者血尿在3天内消失,随访时IPSS下降10分。结论:本病例突出了源自股总动脉的前列腺动脉的一种明显罕见的变异,强调了在PAE期间需要仔细的术前计划和警惕,以避免并发症。
{"title":"Prostatic artery from an extrapelvic obturator artery: a rare common femoral artery variant with clinical implications.","authors":"Omar Ayman, Paul Bennett Lewis","doi":"10.1186/s42155-025-00594-3","DOIUrl":"10.1186/s42155-025-00594-3","url":null,"abstract":"<p><strong>Background: </strong>Prostate artery embolization (PAE) is an established treatment option for benign prostatic hyperplasia (BPH). Variations in prostatic artery (PA) origins can present significant technical challenges.</p><p><strong>Case presentation: </strong>An 86-year-old male with recurrent bladder cancer and persistent gross hematuria post-TURBT presented for PAE. Intra-procedural angiography revealed a prostatic artery branching from an aberrant obturator artery that originated from a trifurcation of the common femoral artery. PAE was successfully performed with contralateral access and particle embolization. The patient's hematuria resolved within 3 days, and his IPSS decreased by 10 points at follow-up.</p><p><strong>Conclusion: </strong>This case highlights a markedly rare variant of the prostatic artery arising from the common femoral artery, emphasizing the need for careful pre-procedural planning and vigilance during PAE to avoid complications.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"79"},"PeriodicalIF":1.5,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12514087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous transluminal angioplasty vs. stenting for hepatic artery stenosis after liver transplantation in adults: a systematic review and meta-analysis. 成人肝移植术后肝动脉狭窄经皮腔内血管成形术与支架置入术:一项系统回顾和荟萃分析。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-07 DOI: 10.1186/s42155-025-00581-8
Mahmoud Shaaban Abdelgalil, Ahmad Abdelrazek, Adam Hraybi, Marwa Hassanien, Abid Wazir, Akram Elegili, Abdelrahman Abdelrazek, Hammad Tanoli, Sara Metwally

Purpose: Hepatic artery stenosis (HAS) is a serious complication of liver transplantation (LT), with no established guidelines for choosing between percutaneous transluminal Angioplasty (PTA) and stent. This study compared their outcomes to inform clinical practice.

Materials and methods: We searched PubMed, SCOPUS, Cochrane library, and Web of Science for studies comparing PTA and stenting in HAS patients after LT. The primary outcome was primary patency rate. Secondary outcomes included technical success, major complications, Hepatic artery thrombosis (HAT) incidence, reintervention rates, and time to recurrent HAS. We also conducted a subgroup analysis based on major complication types, specifically artery dissection and rupture.

Results: Nine observational studies, including 325 patients with HAS after LT, were analyzed, with 140 treated with PTA alone and 197 with stents. No significant differences were found between stenting and PTA in primary patency rates at 6 months, 12 months, and the end of follow-up, as well as in technical success, major complications, artery dissection, artery rupture, and HAT incidence. However, stenting was significantly associated with a lower reintervention rate (RR = 0.57, 95% CI [0.36, 0.89], P = 0.01) and a longer time to recurrent HAS compared to PTA (MD = 36.42, 95% CI [14.14, 58.70], P = 0.001).

Conclusion: Both PTA and stenting show similar primary patency and safety for HAS after LT. However, stenting offers lower reintervention rates and longer recurrence-free intervals, suggesting better long-term outcomes. Treatment selection should be individualized, considering anatomical factors, stenosis morphology, and operator expertise.

目的:肝动脉狭窄(HAS)是肝移植(LT)的严重并发症,在经皮腔内血管成形术(PTA)和支架之间的选择尚无明确的指南。这项研究比较了他们的结果,为临床实践提供信息。材料和方法:我们检索了PubMed、SCOPUS、Cochrane图书馆和Web of Science,以比较PTA和支架植入在lt后HAS患者中的应用。主要结果为原发性通畅率。次要结局包括技术成功、主要并发症、肝动脉血栓形成(HAT)发生率、再干预率和复发HAS的时间。我们还根据主要并发症类型进行了亚组分析,特别是动脉夹层和破裂。结果:我们分析了9项观察性研究,包括325例肝移植后HAS患者,其中140例单独使用PTA治疗,197例支架治疗。支架术和PTA在6个月、12个月和随访结束时的初级通畅率,以及技术成功率、主要并发症、动脉夹层、动脉破裂和HAT发生率方面均无显著差异。然而,与PTA相比,支架置入术与较低的再干预率(RR = 0.57, 95% CI [0.36, 0.89], P = 0.01)和较长的复发时间相关(MD = 36.42, 95% CI [14.14, 58.70], P = 0.001)。结论:PTA和支架置入术对于肝移植后的ha具有相似的初始通畅性和安全性。然而,支架置入术具有较低的再干预率和较长的无复发间隔,表明较好的长期预后。治疗选择应个体化,考虑解剖因素,狭窄形态和操作人员的专业知识。
{"title":"Percutaneous transluminal angioplasty vs. stenting for hepatic artery stenosis after liver transplantation in adults: a systematic review and meta-analysis.","authors":"Mahmoud Shaaban Abdelgalil, Ahmad Abdelrazek, Adam Hraybi, Marwa Hassanien, Abid Wazir, Akram Elegili, Abdelrahman Abdelrazek, Hammad Tanoli, Sara Metwally","doi":"10.1186/s42155-025-00581-8","DOIUrl":"10.1186/s42155-025-00581-8","url":null,"abstract":"<p><strong>Purpose: </strong>Hepatic artery stenosis (HAS) is a serious complication of liver transplantation (LT), with no established guidelines for choosing between percutaneous transluminal Angioplasty (PTA) and stent. This study compared their outcomes to inform clinical practice.</p><p><strong>Materials and methods: </strong>We searched PubMed, SCOPUS, Cochrane library, and Web of Science for studies comparing PTA and stenting in HAS patients after LT. The primary outcome was primary patency rate. Secondary outcomes included technical success, major complications, Hepatic artery thrombosis (HAT) incidence, reintervention rates, and time to recurrent HAS. We also conducted a subgroup analysis based on major complication types, specifically artery dissection and rupture.</p><p><strong>Results: </strong>Nine observational studies, including 325 patients with HAS after LT, were analyzed, with 140 treated with PTA alone and 197 with stents. No significant differences were found between stenting and PTA in primary patency rates at 6 months, 12 months, and the end of follow-up, as well as in technical success, major complications, artery dissection, artery rupture, and HAT incidence. However, stenting was significantly associated with a lower reintervention rate (RR = 0.57, 95% CI [0.36, 0.89], P = 0.01) and a longer time to recurrent HAS compared to PTA (MD = 36.42, 95% CI [14.14, 58.70], P = 0.001).</p><p><strong>Conclusion: </strong>Both PTA and stenting show similar primary patency and safety for HAS after LT. However, stenting offers lower reintervention rates and longer recurrence-free intervals, suggesting better long-term outcomes. Treatment selection should be individualized, considering anatomical factors, stenosis morphology, and operator expertise.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"78"},"PeriodicalIF":1.5,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12501083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posttraumatic urethral hemorrhage associated with an arteriospongious fistula and managed with catheter-directed embolization: a report of 2 cases. 创伤后尿道出血伴动脉海绵瘘,经导管栓塞治疗:附2例报告。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-02 DOI: 10.1186/s42155-025-00593-4
Stijn De Bondt, Steven Joniau, Maarten Albersen, Geert Maleux

Background: Urethral bleeding can be related to iatrogenic and non-iatrogenic trauma; selective internal iliac angiography may identify contrast extravasation with or without a pseudoaneurysm at the level of the distal internal pudendal or bulbourethral artery. Here, we describe another, yet unreported vascular lesion of the bulbourethral artery related to urethral injury.

Case presentation: Two patients with a iatrogenic and non-iatrogenic urethral bleeding respectively are presented. Conservative management, including Foley catheter placement and endoscopic management were unsuccessful. Selective internal pudendal angiography revealed an arteriospongious fistula without clear contrast extravasation into the urethral lumen; super-selective embolization with microcoils and non-adhesive liquid embolics was safely performed and successfully stopped the bleeding. The postinterventional course was uneventful and both patients recovered without sequelae.

Conclusions: Traumatic urethral bleeding might be related to an arteriospongious fistula which can be successfully managed with super-selective coil and liquid embolic embolization.

背景:尿道出血可能与医源性和非医源性创伤有关;选择性髂内血管造影可以鉴别在阴部内动脉或球尿道动脉远端水平有或没有假性动脉瘤的造影剂外渗。在这里,我们描述了另一个尚未报道的与尿道损伤有关的球尿道动脉血管病变。病例介绍:本文报告两例分别为医源性和非医源性尿道出血的患者。保守治疗包括Foley置管和内镜治疗均未成功。选择性阴部内血管造影显示一动海绵状瘘,未见造影剂明显外渗尿道腔;采用微线圈和非粘性液体栓塞进行超选择性栓塞,安全成功止血。介入后疗程顺利,两名患者均无后遗症。结论:外伤性尿道出血可能与动脉海绵瘘有关,可采用超选择性线圈和液体栓塞治疗。
{"title":"Posttraumatic urethral hemorrhage associated with an arteriospongious fistula and managed with catheter-directed embolization: a report of 2 cases.","authors":"Stijn De Bondt, Steven Joniau, Maarten Albersen, Geert Maleux","doi":"10.1186/s42155-025-00593-4","DOIUrl":"10.1186/s42155-025-00593-4","url":null,"abstract":"<p><strong>Background: </strong>Urethral bleeding can be related to iatrogenic and non-iatrogenic trauma; selective internal iliac angiography may identify contrast extravasation with or without a pseudoaneurysm at the level of the distal internal pudendal or bulbourethral artery. Here, we describe another, yet unreported vascular lesion of the bulbourethral artery related to urethral injury.</p><p><strong>Case presentation: </strong>Two patients with a iatrogenic and non-iatrogenic urethral bleeding respectively are presented. Conservative management, including Foley catheter placement and endoscopic management were unsuccessful. Selective internal pudendal angiography revealed an arteriospongious fistula without clear contrast extravasation into the urethral lumen; super-selective embolization with microcoils and non-adhesive liquid embolics was safely performed and successfully stopped the bleeding. The postinterventional course was uneventful and both patients recovered without sequelae.</p><p><strong>Conclusions: </strong>Traumatic urethral bleeding might be related to an arteriospongious fistula which can be successfully managed with super-selective coil and liquid embolic embolization.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"77"},"PeriodicalIF":1.5,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12491119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tunneled dialysis catheter placement in intensive care unit patients: influence of catheter tip design on clinical performance. 重症监护病房患者隧道透析置管:导管尖端设计对临床表现的影响。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-29 DOI: 10.1186/s42155-025-00596-1
Alexey Gurevich, Gregory J Nadolski, Ansar Z Vance, Ryan-Assaad El-Ghazal, Raphael Cohen, Timothy W I Clark, Matthew L Hung

Purpose: This study evaluates catheter failure rates between a helical-tip catheter and a traditional split-tip catheter among intensive care unit (ICU) patients undergoing tunneled dialysis catheter (TDC) placement.

Materials and methods: We analyzed 1734 TDCs placed over seven years in a retrospective fashion, focusing on 340 catheters used in an ICU setting. Of these, 112 were VectorFlow catheters (32.9%), and 228 were Ash-Split catheters (67.1%). Catheter failure rates due to malfunction or infection were assessed using Kaplan-Meier analysis, while contributing factors were evaluated using Cox proportional hazards modeling.

Results: Within 90 days, 34.8% of patients experienced catheter failure. The VectorFlow catheter demonstrated superior unassisted patency at 30, 60, 90, and 180 days compared to the Ash-Split catheter (87.4 ± 3.6%, 78.0 ± 5.1%, 75.1 ± 5.0% and 60.1 ± 8.2% compared with 75.0 ± 3.3%, 62.8 ± 4.1%, 60.7 ± 4.2% and 44.3 ± 5.5% respectively, P = 0.022). Adjusted hazard ratios indicated Ash-Split catheters were nearly twice as likely to fail according to both univariate (1.72, P = 0.024) and multivariate (1.89, P = 0.017) modeling.

Conclusion: The findings suggest that the VectorFlow catheter demonstrates significantly better primary unassisted patency over the Ash-Split design in ICU settings, supporting its preferential use.

目的:本研究评估重症监护病房(ICU)患者行隧道透析导管(TDC)置入时螺旋尖导管与传统裂尖导管的失败率。材料和方法:我们以回顾性的方式分析了7年来放置的1734个tdc,重点是在ICU环境中使用的340个导管。其中VectorFlow导管112例(32.9%),Ash-Split导管228例(67.1%)。使用Kaplan-Meier分析评估因故障或感染导致的导管失败率,使用Cox比例风险模型评估影响因素。结果:90天内34.8%的患者出现导管失效。与Ash-Split导管相比,VectorFlow导管在30、60、90和180天的独立通畅性均优于Ash-Split导管(分别为87.4±3.6%、78.0±5.1%、75.1±5.0%和60.1±8.2%,分别为75.0±3.3%、62.8±4.1%、60.7±4.2%和44.3±5.5%,P = 0.022)。根据单因素(1.72,P = 0.024)和多因素(1.89,P = 0.017)模型,调整后的风险比表明,Ash-Split导管失败的可能性几乎是其两倍。结论:研究结果表明,在ICU环境下,VectorFlow导管比Ash-Split设计具有更好的初级无辅助通畅性,支持其优先使用。
{"title":"Tunneled dialysis catheter placement in intensive care unit patients: influence of catheter tip design on clinical performance.","authors":"Alexey Gurevich, Gregory J Nadolski, Ansar Z Vance, Ryan-Assaad El-Ghazal, Raphael Cohen, Timothy W I Clark, Matthew L Hung","doi":"10.1186/s42155-025-00596-1","DOIUrl":"10.1186/s42155-025-00596-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates catheter failure rates between a helical-tip catheter and a traditional split-tip catheter among intensive care unit (ICU) patients undergoing tunneled dialysis catheter (TDC) placement.</p><p><strong>Materials and methods: </strong>We analyzed 1734 TDCs placed over seven years in a retrospective fashion, focusing on 340 catheters used in an ICU setting. Of these, 112 were VectorFlow catheters (32.9%), and 228 were Ash-Split catheters (67.1%). Catheter failure rates due to malfunction or infection were assessed using Kaplan-Meier analysis, while contributing factors were evaluated using Cox proportional hazards modeling.</p><p><strong>Results: </strong>Within 90 days, 34.8% of patients experienced catheter failure. The VectorFlow catheter demonstrated superior unassisted patency at 30, 60, 90, and 180 days compared to the Ash-Split catheter (87.4 ± 3.6%, 78.0 ± 5.1%, 75.1 ± 5.0% and 60.1 ± 8.2% compared with 75.0 ± 3.3%, 62.8 ± 4.1%, 60.7 ± 4.2% and 44.3 ± 5.5% respectively, P = 0.022). Adjusted hazard ratios indicated Ash-Split catheters were nearly twice as likely to fail according to both univariate (1.72, P = 0.024) and multivariate (1.89, P = 0.017) modeling.</p><p><strong>Conclusion: </strong>The findings suggest that the VectorFlow catheter demonstrates significantly better primary unassisted patency over the Ash-Split design in ICU settings, supporting its preferential use.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"74"},"PeriodicalIF":1.5,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bariatric embolization with N-butyl cyanoacrylate glue: a revival. 用氰基丙烯酸酯正丁胶进行减肥栓塞:复兴。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-29 DOI: 10.1186/s42155-025-00602-6
Romaric Loffroy
{"title":"Bariatric embolization with N-butyl cyanoacrylate glue: a revival.","authors":"Romaric Loffroy","doi":"10.1186/s42155-025-00602-6","DOIUrl":"10.1186/s42155-025-00602-6","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"76"},"PeriodicalIF":1.5,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IR beyond the procedure: mastering patient and team management. 超越程序:掌握病人和团队管理。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-29 DOI: 10.1186/s42155-025-00592-5
Sara Lojo-Lendoiro, Jose Andrés Guirola Ortiz, Velio Ascenti, Anna Maria Ierardi

Interventional Radiology (IR) has evolved far beyond its procedural roots, offering advanced treatments in oncology, vascular disease, and trauma. Its future, however, depends on deeper integration into clinical workflows, patient management, and multidisciplinary collaboration. Barriers such as limited participation in care teams, absence of outpatient consultation structures, and insufficient clinical training hinder IR's ability to fully own patient care, reducing visibility and delaying referrals. To reframe IR as a true clinical specialty, several actions are needed: expand integration through tumor boards, ward rounds, and follow-up clinics; strengthen patient-centered communication to support trust and informed consent; assume leadership roles to improve workflows, staffing, and institutional decision-making; reform training with broader clinical exposure, simulation, and standardized certification (e.g., EBIR); and establish structural consistency across departments to unify identity and foster collaboration. The future of IR lies in combining technical expertise with patient engagement, interdisciplinary cooperation, and clinical leadership-ensuring it becomes a central, not peripheral, force in modern healthcare. This review will explore the evolving role of interventional radiologists in patient management, with particular emphasis on their integration into hospital-based multidisciplinary teams. It will examine their participation in clinical decision-making, interprofessional communication, and strategies to enhance the visibility and recognition of IR among both patients and healthcare providers.

介入放射学(IR)的发展已经远远超出了它的程序根源,为肿瘤、血管疾病和创伤提供了先进的治疗方法。然而,它的未来取决于与临床工作流程、患者管理和多学科合作的更深层次的整合。诸如参与护理团队有限、缺乏门诊咨询结构和临床培训不足等障碍阻碍了IR完全拥有患者护理的能力,降低了可见度并延迟了转诊。为了将IR重新定位为一门真正的临床专业,需要采取以下措施:通过肿瘤委员会、查房和随访诊所扩大整合;加强以患者为中心的沟通,支持信任和知情同意;承担领导角色,改进工作流程、人员配置和机构决策;改革培训,扩大临床接触、模拟和标准化认证(如EBIR);建立跨部门的结构一致性,统一身份,促进合作。IR的未来在于将技术专长与患者参与、跨学科合作和临床领导相结合,确保它成为现代医疗保健的核心力量,而不是外围力量。本综述将探讨介入放射科医生在患者管理中的角色演变,特别强调他们与医院多学科团队的整合。它将检查他们在临床决策、跨专业沟通和策略方面的参与,以提高患者和医疗保健提供者对IR的可见度和认可度。
{"title":"IR beyond the procedure: mastering patient and team management.","authors":"Sara Lojo-Lendoiro, Jose Andrés Guirola Ortiz, Velio Ascenti, Anna Maria Ierardi","doi":"10.1186/s42155-025-00592-5","DOIUrl":"10.1186/s42155-025-00592-5","url":null,"abstract":"<p><p>Interventional Radiology (IR) has evolved far beyond its procedural roots, offering advanced treatments in oncology, vascular disease, and trauma. Its future, however, depends on deeper integration into clinical workflows, patient management, and multidisciplinary collaboration. Barriers such as limited participation in care teams, absence of outpatient consultation structures, and insufficient clinical training hinder IR's ability to fully own patient care, reducing visibility and delaying referrals. To reframe IR as a true clinical specialty, several actions are needed: expand integration through tumor boards, ward rounds, and follow-up clinics; strengthen patient-centered communication to support trust and informed consent; assume leadership roles to improve workflows, staffing, and institutional decision-making; reform training with broader clinical exposure, simulation, and standardized certification (e.g., EBIR); and establish structural consistency across departments to unify identity and foster collaboration. The future of IR lies in combining technical expertise with patient engagement, interdisciplinary cooperation, and clinical leadership-ensuring it becomes a central, not peripheral, force in modern healthcare. This review will explore the evolving role of interventional radiologists in patient management, with particular emphasis on their integration into hospital-based multidisciplinary teams. It will examine their participation in clinical decision-making, interprofessional communication, and strategies to enhance the visibility and recognition of IR among both patients and healthcare providers.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"75"},"PeriodicalIF":1.5,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periarticular cooling reduces non-target perfusion in genicular artery embolization: a quantitative angiographic study. 关节周围冷却减少非靶灌注在膝动脉栓塞:定量血管造影研究。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-26 DOI: 10.1186/s42155-025-00597-0
Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell

Background: Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.

Methodology: This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.

Results: The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm2 to 240.1 ± 208.2 mm2 (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].

Conclusion: Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.

背景:膝动脉栓塞术(GAE)是一种新兴的、有效的治疗症状性膝骨关节炎疼痛的方法。该手术的一个潜在问题是皮下和皮下血管的非靶栓塞,这可能导致严重的皮肤并发症,如坏死。为了降低这种风险,一些作业者采用关节周围冷却,其原理是诱导血管收缩。然而,冷却对非靶皮下血管的收缩作用尚未得到客观证明。本研究旨在为这种常见的安全操作提供第一个客观证据。方法:回顾性分析基于36例患者(39个膝关节)的队列。该研究评估了49个选择性膝内侧或外侧动脉血管造影术,这些血管造影术是基于浅表腮红的存在而分层的。定义了三个队列进行比较:1)冷却队列,包括20个血管造影(来自10个膝盖),显示红肿并接受关节周围冷却治疗。2)腮红对照组,包括18张血管造影术(来自18个膝盖),有腮红但没有冷却操作。3)无脸红对照组(11膝)。定量分析两组浅表腮红在DSA上的腮红面积;在降温组中,对干预前后的腮红面积进行比较,而在腮红控制组中,对基线腮红进行量化。系统地记录皮肤相关不良事件,并在患者水平上对所有三个队列进行比较。结果:应用关节周围冷却使平均腮红面积从464.8±447.6 mm2显著减少到240.1±208.2 mm2 (p = 0.012),相当于平均减少73.8% (p = 0.0006)。接受降温治疗的患者皮肤变化明显少于脸红对照组[中位评分1 vs 2, p = 0.0174]。结论:关节周围冷却是一种简单、无创、有效的技术,可显著减少GAE期间可量化的非靶皮肤灌注。我们的工作提供了客观证据,支持其作为标准的安全增强操作,以尽量减少皮肤相关并发症的风险。
{"title":"Periarticular cooling reduces non-target perfusion in genicular artery embolization: a quantitative angiographic study.","authors":"Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell","doi":"10.1186/s42155-025-00597-0","DOIUrl":"10.1186/s42155-025-00597-0","url":null,"abstract":"<p><strong>Background: </strong>Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.</p><p><strong>Methodology: </strong>This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.</p><p><strong>Results: </strong>The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm<sup>2</sup> to 240.1 ± 208.2 mm<sup>2</sup> (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].</p><p><strong>Conclusion: </strong>Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"73"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145151943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of Trans-collateral revascularization of infrapopliteal vessels: A Single-center retrospective study. 经侧支腘下血管重建术的有效性和安全性:一项单中心回顾性研究。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-26 DOI: 10.1186/s42155-025-00595-2
Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji

Background: Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.

Results: This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.

Conclusions: Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.

背景:血管内治疗(EVT)已成为慢性肢体威胁性缺血(CLTI)患者的关键血运重建策略,特别是涉及膝下(IP)慢性全闭塞(CTOs)的病例,这种情况通常难以仅使用标准顺行入路治疗。经侧支血管成形术(TCA)是一种逆行技术,当传统方法不成功时,通过侧支血管进入远端真腔。然而,关于TCA的有效性和安全性的临床证据仍然不足。本研究旨在评估TCA逆行入路治疗IP CTO病变EVT的有效性和安全性。结果:这项回顾性单中心研究包括了2020年1月至2022年12月期间接受TCA治疗的44例IP CTO病变,排除了18例仅用足底环技术治疗的病变。患者平均年龄为78.8岁,81.8%患有糖尿病,79.5%患有慢性肾脏疾病,31.8%接受透析治疗。EVT的成功率为95.5% (95% CI: 84.9-98.7)。70.5% (95% CI: 55.8-81.8)的病例仅通过TCA实现病灶交叉,13.6% (95% CI: 6.4-27.0)的病例需要远端穿刺。进行了各种交叉技术,包括交会技术和反向内膜下跟踪。侧枝血管相关并发症发生率为11.3%(5个病变;95% CI: 5.0-24.6),包括损伤6.8%,闭塞和痉挛2.3%。无血管夹层发生。30天内围手术期并发症的总发生率为20.5% (95% CI: 11.3-34.2),最常见的是胃肠道出血和脑卒中。一年后,目标病灶血运重建的自由率为45.4%,无截肢生存率为84.0%。结论:我们的研究结果表明,当顺行线路失败时,TCA是一种可行且相对安全的逆行治疗复杂IP CTO病变的策略。它具有较高的手术成功率和较低的侧支血管相关并发症发生率,支持其在特定CLTI病例中的应用。
{"title":"Efficacy and safety of Trans-collateral revascularization of infrapopliteal vessels: A Single-center retrospective study.","authors":"Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji","doi":"10.1186/s42155-025-00595-2","DOIUrl":"10.1186/s42155-025-00595-2","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.</p><p><strong>Results: </strong>This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.</p><p><strong>Conclusions: </strong>Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"72"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A few final thoughts as outgoing editor-in-chief. 作为即将卸任的总编,我有一些最后的想法。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1186/s42155-025-00598-z
Jim A Reekers
{"title":"A few final thoughts as outgoing editor-in-chief.","authors":"Jim A Reekers","doi":"10.1186/s42155-025-00598-z","DOIUrl":"10.1186/s42155-025-00598-z","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"71"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CVIR Endovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1